Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04197570Phase 3Completed
Phase 3, randomised, double-blind trial of dexmedetomidine in pain, sponsored by Benaroya Research Institute. Primary endpoint: Mean arterial blood pressure-time integral at 10 minutes. Started Feb 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04197570.